NOV 2013

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/220233

Contents of this Issue


Page 83 of 122

Inflammation and generic pharmaceuticals Interestingly, there were significant differences between U.S. and non-U.S. doctors on their use of anti-inflammatory drugs for preloading and the concurrent use of NSAIDs and steroids together. Also 17% of surgeons are still considering 1+ cell and flare levels as normal in their practice. Less than half of respondents strongly agree that low-to-moderate inflammation has visual quality and recovery impact. The vast majority of respondents conclude that using both NSAIDs and corticosteroids together to block the inflammatory cascade was important after cataract surgery. Slightly more U.S. respondents felt this way compared to their international colleagues. While about half of respondents are prescribing brand name only pharmaceuticals, they think that about half of the time these are being substituted anyway by the pharmacy. About two-thirds of respondents believe that there is a significant difference between brand name and generic drugs on patient outcomes and safety. 5

Articles in this issue

Archives of this issue

view archives of Eyeworld - NOV 2013